1. Home
  2. Analysis
  3. Temaz
  4. Kantrex

Temaz and Kantrex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temaz (temazepam) and Kantrex (kanamycin sulfate). Common drug interactions include back pain among males.

The phase IV clinical study analyzes what interactions people have when they take Temaz and Kantrex. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.

What is Kantrex?

Kantrex has active ingredients of kanamycin sulfate. eHealthMe is studying from 33 Kantrex users. Check the latest studies of Kantrex.

On Jul, 08, 2026

13 people who take Temaz and Kantrex together, and have interactions are studied.

Temaz and Kantrex drug interactions.

What are the common drug interactions of Temaz and Kantrex, by gender? *:

female:

n/a

male:

  1. Back pain
  2. Arthralgia (joint pain)
  3. Dental caries
  4. Disability
  5. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  6. Hypertension (high blood pressure)
  7. Neuritis (inflammation of nerve)
  8. Neuropathy peripheral (surface nerve damage)
  9. Osteomyelitis (infection of bone)
  10. Osteonecrosis of jaw (death of bone of jaw)

What are the common drug interactions of Temaz and Kantrex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain
  2. Affective disorder (mental disorder)
  3. Aortic valve sclerosis (narrowing of the aortic valve)
  4. Apathy
  5. Arthralgia (joint pain)
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  7. Arthropathy
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Back pain
  10. Balance disorder

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 9 people, 69.23%
  2. Metastases To Prostate (cancer spreads to prostate): 7 people, 53.85%
  3. Prostate Cancer Metastatic: 2 people, 15.38%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 7.69%
  5. Stress And Anxiety: 1 person, 7.69%
  6. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 7.69%
  7. Panic Disorder: 1 person, 7.69%
  8. Pain: 1 person, 7.69%
  9. Osteoporotic Fracture (fracture due to weak bone): 1 person, 7.69%
  10. Osteoporosis (bones weak and more likely to break): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Temaz and Kantrex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temaz and Kantrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kantrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kantrex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and kanamycin sulfate (the active ingredients of Temaz and Kantrex, respectively), and Temaz and Kantrex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.